North America Blood Screening Market Size & Outlook

The blood screening market in North America is expected to reach a projected revenue of US$ 2,400.9 million by 2030. A compound annual growth rate of 10.8% is expected of North America blood screening market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,302.4
Forecast, 2030 (US$M)
$2,400.9
CAGR, 2025 - 2030
10.8%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America blood screening market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America blood screening market highlights

  • The North America blood screening market generated a revenue of USD 1,302.4 million in 2024.
  • The market is expected to grow at a CAGR of 10.8% from 2025 to 2030.
  • In terms of segment, nucleic acid amplification test was the largest revenue generating technology in 2024.
  • Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.


North America data book summary

Market revenue in 2024USD 1,302.4 million
Market revenue in 2030USD 2,400.9 million
Growth rate10.8% (CAGR from 2025 to 2030)
Largest segmentNucleic acid amplification test
Fastest growing segmentNext Generation Sequencing
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting
Key market players worldwideAbbott Laboratories, Danaher Corp, Becton Dickinson & Co, Bio-Rad Laboratories Inc, Roche Holding AG, Grifols SA Ordinary Shares - Class A, Siemens AG, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, North America region accounted for 38.4% of the global blood screening market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,579.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood Screening Market Companies

Name Profile # Employees HQ Website
Grifols SA Ordinary Shares - Class A View profile 23737 Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 https://www.grifols.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens AG View profile 321000 Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 https://www.siemens.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

North America blood screening market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood screening market will help companies and investors design strategic landscapes.


Nucleic acid amplification test was the largest segment with a revenue share of 43.63% in 2024. Horizon Databook has segmented the North America blood screening market based on nucleic acid amplification test, elisa, chemiluminescence immunoassay, next generation sequencing, western blotting covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America blood screening market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America blood screening market databook

  • Our clientele includes a mix of blood screening market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America blood screening market, including forecasts for subscribers. This continent databook contains high-level insights into North America blood screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America blood screening market size, by country, 2018-2030 (US$M)

North America Blood Screening Market Share, 2024 & 2030 (US$M)

North America blood screening market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online